In addition, SP1 is one of the substrates of Erk1/2 signaling pathway, and activated by phosphorylation of Erk1/2.36 We hypothesize that Erk1/2 phosphorylation upregulates the expression of Syncytin‐1 by activating SP1, thereby promoting tumor growth. The gene discussed is MAPK3; the disease is neoplasm.